JMFit: A SAS Macro for Joint Models of Longitudinal and Survival Data
Zhang, Danjie, Chen, Ming-Hui, Ibrahim, Joseph G, Boye, Mark E, Shen, Wei
Published in Journal of statistical software (01.07.2016)
Published in Journal of statistical software (01.07.2016)
Get full text
Journal Article
Bayesian Model Assessment in Joint Modeling of Longitudinal and Survival Data With Applications to Cancer Clinical Trials
Zhang, Danjie, Chen, Ming-Hui, Ibrahim, Joseph G., Boye, Mark E., Shen, Wei
Published in Journal of computational and graphical statistics (01.01.2017)
Published in Journal of computational and graphical statistics (01.01.2017)
Get full text
Journal Article
Validity of 24-h recall ratings of pain severity: Biasing effects of “Peak” and “End” pain
Jensen, Mark P., Mardekian, Jack, Lakshminarayanan, Mani, Boye, Mark E.
Published in Pain (Amsterdam) (15.07.2008)
Published in Pain (Amsterdam) (15.07.2008)
Get full text
Journal Article
Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S
Kumar, Gayathri, Woods, Beth, Hess, Lisa M, Treat, Joseph, Boye, Mark E, Bryden, Peter, Winfree, Katherine B
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2015)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2015)
Get full text
Journal Article
Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery
NUSSMEIER, Nancy A, WHELTON, Andrew A, BROWN, Mark T, JOSHI, Girish P, LANGFORD, Richard M, SINGLA, Neil K, BOYE, Mark E, VERBURG, Kenneth M
Published in Anesthesiology (Philadelphia) (01.03.2006)
Published in Anesthesiology (Philadelphia) (01.03.2006)
Get full text
Journal Article
Joint Modeling of Multiple Longitudinal Patient-Reported Outcomes and Survival
Hatfield, Laura A., Boye, Mark E., Carlin, Bradley P.
Published in Journal of biopharmaceutical statistics (01.09.2011)
Published in Journal of biopharmaceutical statistics (01.09.2011)
Get full text
Journal Article
Economic Burden of Follicular Non-Hodgkin’s Lymphoma
Foster, Talia, Miller, Jeffrey D., Boye, Mark E., Russell, Mason W.
Published in PharmacoEconomics (01.01.2009)
Published in PharmacoEconomics (01.01.2009)
Get full text
Journal Article
KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis
Goulding, Rebecca Ellen, Chenoweth, Matthew, Carter, Gebra Cuyun, Boye, Mark Ernest, Sheffield, Kristin M, John, William J, Leusch, Mark Steven, Muehlenbein, Catherine Elizabeth, Li, Li, Jen, Min-Hua, Rojubally, Adina, Jansen, Jeroen, Druyts, Eric
Published in Cancer treatment and research communications (2020)
Published in Cancer treatment and research communications (2020)
Get full text
Journal Article
Safety of Parecoxib and Valdecoxib after Noncardiac Surgery: Lack of Demonstration
Nussmeier, Nancy A., Whelton, Andrew, Brown, Mark T., Joshi, Girish P., Langford, Richard M., Singla, Neil K., Boye, Mark E., Verburg, Kenneth M.
Published in Anesthesiology (Philadelphia) (01.01.2007)
Published in Anesthesiology (Philadelphia) (01.01.2007)
Get full text
Journal Article
Real-world health-related quality of life and caregiver need in patients with metastatic hormone-sensitive and metastatic castration-resistant prostate cancer
Boye, Mark, Ribbands, Amanda, Leith, Andrea, Clayton, Emily, Butcher, Jake, Rybowski, Sarah
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group
Lawrence Gould, A., Boye, Mark Ernest, Crowther, Michael J., Ibrahim, Joseph G., Quartey, George, Micallef, Sandrine, Bois, Frederic Y.
Published in Statistics in medicine (30.06.2015)
Published in Statistics in medicine (30.06.2015)
Get full text
Journal Article
Immune-related adverse events and efficacy outcomes in patients treated with immunotherapy: A systematic review and meta-analysis
Druyts, Eric, Boye, Mark, Agg, Himani, Muehlenbein, Catherine, Frederickson, Andrew, Bayt, Theresa
Published in Journal of clinical oncology (10.02.2020)
Published in Journal of clinical oncology (10.02.2020)
Get full text
Journal Article
Estimating the effects of patient-reported outcome (PRO) diarrhea and pain measures on PRO fatigue: Data analysis from a phase II study of abemaciclib monotherapy, a CDK4 and CDK6 inhibitor, in patients with HR+/HER2- breast cancer after chemotherapy for metastatic disease—MONARCH 1
Boye, Mark, Houghton, Katherine, Stull, Donald E, Ainsworth, Claire, Price, Gregory L
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Health-related quality of life (HRQoL) in MONARCH 2: Abemaciclib plus fulvestrant in women with HR+, HER2- advanced breast cancer (ABC) who progressed on endocrine therapy
Kaufman, Peter A., Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Price, Gregory L, Lin, Yong, Boye, Mark, Li, Li, Gable, Jonathon, Cuyun Carter, Gebra, Sledge, George W.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article